Keyphrases
G Protein-coupled Receptor
100%
M2 muscarinic Receptor
56%
Voltage Dependence
52%
Membrane Potential
25%
5-HT1A Receptor
21%
Signal Transduction
21%
Olfactory Sensory Neuron
19%
Serotonergic
19%
Voltage Sensor
19%
CB1 Receptor
19%
G Protein
19%
Xenopus Oocytes
19%
Na +
16%
Sodium Ion
16%
Transduction Process
15%
Ca2+
12%
Receptor-mediated
12%
Receptor Activation
11%
Muscarinic Receptors
11%
Cannabinoid Receptor 1 (CB1R)
10%
Charge Motion
10%
Tetrahydrocannabinol
9%
Antidepressants
9%
Neuronal Behavior
9%
Vertebrates
9%
Anxiolytic Activity
9%
Neurotransmitter Release
9%
Dissociation Rate Constant
9%
Gate Charge
9%
Ligand Binding
9%
Nucleolin
9%
Splice Site Selection
9%
Cyclic nucleotide-gated
9%
Cation Current
9%
Receptor Subtypes
9%
Functional Consequences
9%
Serotonergic System
9%
Sodium Levels
9%
Cannabis
9%
Voltage Level
9%
Orthosteric Binding Site
9%
Synergize
9%
Terpenes
9%
Crataegus pinnatifida
9%
Neural Plasticity
9%
Shan
9%
Biochemical Mechanism
9%
Muscarinic Antagonists
9%
Allosteric Modulator
9%
Depolarization
9%
Neuroscience
G Protein Coupled Receptor
99%
Muscarinic M2 Receptor
56%
Eicosanoid Receptor
37%
Cell Signaling
29%
Agonist
24%
5-HT1A Receptor
21%
G Protein
21%
Olfactory Receptor Neuron
19%
Serotonergic
19%
Cannabinoid 1 Receptor
19%
Membrane Potential
16%
Serotonin
13%
Behavior (Neuroscience)
13%
Binding Site
11%
Neurotransmitter Release
9%
Tetrahydrocannabinol
9%
Antidepressant
9%
Cyclic Nucleotide
9%
Ligand Binding
9%
Neuronal Plasticity
9%
Cannabis
9%
Muscarinic Antagonist
9%
Gene Expression System
9%
5-HT Receptor
8%
Muscarinic Acetylcholine Receptor
8%
Aspartic Acid
6%
Acetylcholine
6%
Escitalopram
5%
Brain Function
5%
Pharmacology, Toxicology and Pharmaceutical Science
G Protein Coupled Receptor
35%
Muscarinic M2 Receptor
29%
Receptor
20%
Cannabinoid 1 Receptor
19%
Guanine Nucleotide Binding Protein
13%
Binding Site
11%
Antidepressant
9%
Cannabis
9%
Tetrahydrocannabinol
9%
Crataegus pinnatifida
9%
Muscarinic M2 Receptor Antagonist
9%
Allosteric Modulator
9%
Xenopus
8%
Herbal Treatment
7%
Escitalopram
5%